Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 8 résultats.
    • Article de périodique
    Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer
    Schlumberger, Martin J Elisei, Rossella Bastholt, Lars Wirth, Lori J Martins, Renato G Locati, Laura D Jarzab, Barbara Pacini, Furio Daumerie, Chantal[UCL] Droz, Jean-Pierre Eschenberg, Michael J Sun, Yu-Nien Juan, Todd Stepan, Daniel E Sherman, Steven I (2009) Journal of Clinical Oncology — Vol. 27, no. 23, p. 3794-3801 (2009)
    • Article de périodique
    Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
    Baudelet, Christine[UCL] Ansiaux, Réginald[UCL] Jordan, Bénédicte[UCL] Havaux, Xavier[UCL] Macq, Benoît[UCL] Gallez, Bernard[UCL] (2004) Physics in Medicine and Biology — Vol. 49, no. 15, p. 3389-3411 (2004)
    • Article de périodique
    Sorafenib in advanced hepatocellular carcinoma.
    Llovet, Josep M Ricci, Sergio Mazzaferro, Vincenzo Hilgard, Philip Gane, Edward Blanc, Jean-Frédéric de Oliveira, Andre Cosme Santoro, Armando Raoul, Jean-Luc Forner, Alejandro Schwartz, Myron Porta, Camillo Zeuzem, Stefan Bolondi, Luigi Greten, Tim F Galle, Peter R Seitz, Jean-François Borbath, Ivan[UCL] Häussinger, Dieter Giannaris, Tom Shan, Minghua Moscovici, Marius Voliotis, Dimitris Bruix, Jordi SHARP Investigators Study Group (2008) The New England journal of medicine — Vol. 359, no.4, p. 378-390 (2008)
    • Article de périodique
    The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model
    Heindryckx, Femke Coulon, Stephanie Terrie, Ellen Casteleyn, Christophe Stassen, Jean-Marie Geerts, Anja Libbrecht, Louis[UCL] Allemeersch, Joke Carmeliet, Peter Colle, Isabelle Van Vlierberghe, Hans (2013) Journal of Hepatology — Vol. 58, no.2, p. 319-328 (2013)
    • Article de périodique
    Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.
    Vandewynckel, Yves-Paul Laukens, Debby Geerts, Anja Vanhove, Chris Descamps, Benedicte Colle, Isabelle Devisscher, Lindsey Bogaerts, Eliene Paridaens, Annelies Verhelst, Xavier Van Steenkiste, Christophe Libbrecht, Louis[UCL] Lambrecht, Bart N Janssens, Sophie Van Vlierberghe, Hans (2014) European Journal of Gastroenterology and Hepatology — Vol. 26, no.8, p. 861-870 (2014)
    • Rapport de recherche
    Sorafenib for the treatment of advanced hepatocellular carcinoma.
    Connock, M Round, J Bayliss, S Tubeuf, Sandy[UCL] Greenheld, W Moore, D (2010)
    • Article de périodique
    Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino, M G Plant, T D Henquin, Jean-Claude[UCL] (1989) British journal of pharmacology — Vol. 98, no. 3, p. 957-65 (1989)
    • Article de périodique
    Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
    Zhu, Andrew X Park, Joon Oh Ryoo, Baek-Yeol Yen, Chia-Jui Poon, Ronnie Pastorelli, Davide Blanc, Jean-Frederic Chung, Hyun Cheol Baron, Ari D Pfiffer, Tulio Eduardo Flesch Okusaka, Takuji Kubackova, Katerina Trojan, Jorg Sastre, Javier Chau, Ian Chang, Shao-Chun Abada, Paolo B Yang, Ling Schwartz, Jonathan D Kudo, Masatoshi Borbath, Ivan[UCL] (2015) The Lancet Oncology — Vol. 16, no. 7, p. 859-870 (2015)